Mycophenolate Mofetil

Treatment for Lupus

Typical Dosage: 1-3g daily

Effectiveness

80%

Safety Score

35%

Clinical Trials

Participants

10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️

Meth💀

Cigarettes🚬

Chemo☢️

Alcohol🍺

Morphine💊

Antibiotics💉

Tylenol💊

Exercise🏃

Water💧

DangerousModerateSafe

Treatment Details

Dosage Range

1-3g daily

Time to Effect

3-6 months

Treatment Duration

6-24 months induction, then maintenance (often lifetime)

Evidence Quality

HIGH

Number Needed to Treat (NNT)

4(Treat 4 patients to see 1 additional successful outcome)

Number Needed to Harm (NNH)

15(Treat 15 patients to see 1 additional serious adverse event)

Confidence Score

85%confidence in effectiveness data

Health Economics

Annual Cost of Care

Drug Cost:$1,000

Monitoring:$800

Side Effect Mgmt:$400

Total Annual:$2,200

Cost-Effectiveness Analysis

Cost-Effectiveness Rating

GOOD

ICER

$45,000/QALY

QALYs Gained

0.7

Outcome-Based Costs

Cost per Responder

$3,667

Cost per Remission

$5,500

Mycophenolate Mofetil Outcomes

for Lupus

Efficacy Outcomes

Overall Effectiveness

+80%

Response Rate

+60%

Remission Rate

+40%

Common Side Effects

Nausea, diarrhea, abdominal pain

+40%

Increased infection risk

+30%

Leukopenia

+15%

Teratogenic

+100%

Sources:

nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials

1 active trial recruiting for Mycophenolate Mofetil in Lupus

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

NCT05538208RECRUITINGPHASE2

View Study

105 participants

INTERVENTIONAL

San Francisco, United States +18 more

Started: Jun 7, 2024

Completed Clinical Trials

10 completed trials for Mycophenolate Mofetil in Lupus

Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis

NCT01042457COMPLETEDPHASE3

View Study

24 participants

INTERVENTIONAL

Bangkok, Thailand

Started: May 1, 2009

A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt

NCT05195086COMPLETED

View Study

122 participants

OBSERVATIONAL

Cairo, Egypt

Started: Jul 1, 2018

Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

NCT00371319COMPLETEDPHASE4

View Study

150 participants

INTERVENTIONAL

Hong Kong, China

Started: Sep 1, 2005